What was life in the fens like in the period known as the dark ages? Archaeologist Susan Oosthuizen revisits the history of an iconic wetland in the light of fresh evidence and paints a compelling portrait of communities in tune with their changeable environment. In doing so, she makes an important contribution to a wider understanding of early medieval landscapes.
Gene editing using ‘molecular scissors’ that snip out and replace faulty DNA could provide an almost unimaginable future for some patients: a complete cure. Cambridge researchers are working towards making the technology cheap and safe, as well as examining the ethical and legal issues surrounding one of the most exciting medical advances of recent times.
Smoking, lack of exercise, bad diet and our genes are all well-known risk factors for heart disease, cancer and diabetes. But, as researchers are beginning to understand, the environment in the womb as we first begin to grow may also determine our future.
India’s booming business centres and gleaming shopping malls mask a grimmer reality. While one section of the population gets richer, another section gets poorer. In the countryside, farmers and others ‘left behind’ by the economic surge find themselves in increasingly desperate circumstances. In many cases their plight, exacerbated by crippling debt, has led to suicide.
In his new book, geographer David Beckingham looks at the rigorous licencing regime that Liverpool’s authorities put in place to tighten their grip on problem drinking in the pubs that proliferated across the city. Similar attitudes frame today’s perceptions of public and private alcohol consumption.
The journals and scrapbooks of Pierre de L’Estoile have for generations provided a vivid picture of France in a time of religious upheaval. Now Cambridge historian Tom Hamilton has written the first book devoted to the life of L’Estoile as a diarist, collector and man about town.
Tony Kouzarides is passionate about ecosystems: well-balanced communities that flourish on mutual and dynamic interactions. But the ecosystems that excite him are not made up of plants, animals and environments. They’re made up of experts.
When a drug fails late on in clinical trials it’s a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an ‘adaptive’ approach to clinical trials and a genetic tool for predicting success are increasing the odds of picking a winner.
Nanotechnology is creating new opportunities for fighting disease – from delivering drugs in smart packaging to nanobots powered by the world’s tiniest engines.